A 4-week-old female infant is brought to the pediatric clinic by her mother due to poor feeding, nasal congestion, and a rash. The infant was born at 39 weeks gestation via uncomplicated vaginal delivery to a 22-year-old primigravida. The mother began prenatal care at 28 weeks gestation, at which time a rapid plasma reagin (RPR) test was nonreactive. At delivery, a repeat maternal RPR was ordered and reported as nonreactive. The mother reports no history of sexually transmitted infections. On examination, the infant is in the 5th percentile for weight. She has copious, blood-tinged nasal discharge. A diffuse, erythematous, maculopapular rash with areas of superficial desquamation is present on the trunk, palms, and soles. The infant cries vigorously when her right arm is palpated and maintains the arm in a rigid, extended position. Abdominal examination reveals the liver edge 4 cm below the right costal margin. Given the high clinical suspicion, a serum RPR is obtained from the infant and returns reactive at a titer of 1:1024. Confirmatory fluorescent treponemal antibody absorption (FTA-ABS) testing is positive. Which of the following best explains the discrepant maternal and infant serologic findings at the time of delivery?
- High concentration of maternal non-treponemal antibodies preventing visible agglutinationCevap
- BCross-reacting antibodies from an infant viral lower respiratory infection causing a false-positive result
- CMaternal intrapartum broad-spectrum antibiotic administration ablating the serologic response
- DSystemic lipid alterations related to a benign transitional neonatal exanthem
- EHumoral immune suppression secondary to inappropriate maternal live-attenuated vaccination